Acute Skin Toxicity and Self-management Ability Among Chinese Breast Cancer Radiotherapy Patients: a Qualitative Study

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2024 May 30

PMID 38814489

Authors

Xiaomeng Lu

Yunteng Yin

Wenhui Geng

Lei Liu

Fengxia Liu

Zhenye Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: Radiation dermatitis is the most common reaction to radiotherapy, almost all breast cancer patients receive radiotherapy on an outpatient basis. Currently, there are no studies on the experience of radiation dermatitis and the ability to self-manage it. Therefore, we aimed to use qualitative approaches to gain a deeper understanding of the actual experiences and self-management ability in order to provide a reference for further improving the effectiveness of self-management and to optimize symptom management strategies.

Methods: A descriptive qualitative study was conducted using purposive sampling to select 17 breast cancer patients undergoing radiotherapy. Semi-structured interviews were conducted from September to November 2023. The Colaizzi seven-step analysis method was used to classify the data into summarized themes.

Results: Four themes were identified from the interview responses: (1) multiple self-reported skin symptoms in breast cancer patients with radiation dermatitis; (2) the multidimensional impact on patient's quality of life, especially pruritus, ulceration; (3) the ability to self-manage radiation dermatitis: strong mental toughness, positive response, and self-doubt; (4) challenges faced: concerns about radiotherapy side effects and recurrence, targeted symptom management and continuity of care after the radiotherapy.

Conclusions: Healthcare professionals should consider patients' self-reported symptoms when assessing radiation dermatitis. For pruritus and pain, we can enhance precision symptom management to improve patients' quality of life. By utilizing information technology tools, we can increase breast cancer patients' ability and confidence in managing radiation dermatitis effectively while enhancing accurate symptom management during radiotherapy.

References

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Jagsi R, Griffith K, Boike T, Walker E, Nurushev T, Grills I . Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. JAMA Oncol. 2015; 1(7):918-30. DOI: 10.1001/jamaoncol.2015.2590. View

Geara F, Eid T, Zouain N, Thebian R, Andraos T, Chehab C . Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer. Am J Clin Oncol. 2018; 41(12):1257-1262. DOI: 10.1097/COC.0000000000000460. View

Baines C, McGuiness W, ORourke G . An integrative review of skin assessment tools used to evaluate skin injury related to external beam radiation therapy. J Clin Nurs. 2016; 26(7-8):1137-1144. DOI: 10.1111/jocn.13430. View

Bhattacharya I, Haviland J, Hopwood P, Coles C, Yarnold J, Bliss J . Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial. Radiother Oncol. 2019; 134:220-230. PMC: 6486395. DOI: 10.1016/j.radonc.2019.01.036. View

Chen A, Setser A, Anadkat M, Cotliar J, Olsen E, Garden B . Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. J Am Acad Dermatol. 2012; 67(5):1025-39. DOI: 10.1016/j.jaad.2012.02.010. View

Queiroz Schmidt F, Serna Gonzalez C, Mattar R, Lopes L, Santos M, Santos V . Topical application of a cream containing nanoparticles with vitamin E for radiodermatitis prevention in women with breast cancer: A randomized, triple-blind, controlled pilot trial. Eur J Oncol Nurs. 2022; 61:102230. DOI: 10.1016/j.ejon.2022.102230. View

McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383(9935):2127-35. PMC: 5015598. DOI: 10.1016/S0140-6736(14)60488-8. View

Alleva J, Diedrichs P, Halliwell E, Peters M, Dures E, Stuijfzand B . More than my RA: A randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program. J Consult Clin Psychol. 2018; 86(8):666-676. DOI: 10.1037/ccp0000317. View

10.

Laugsand E, Sprangers M, Bjordal K, Skorpen F, Kaasa S, Klepstad P . Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes. 2010; 8:104. PMC: 2949821. DOI: 10.1186/1477-7525-8-104. View

11.

Cunha C, Fernandes R, Santos C, Boccaletti K, Pellizzon A, Oliveira Barbosa J . Viability of mobile applications for remote support of radiotherapy patients. Rev Assoc Med Bras (1992). 2019; 65(10):1321-1326. DOI: 10.1590/1806-9282.65.10.1321. View

12.

Faithfull S, Lemanska A, Chen T . Patient-reported Outcome Measures in Radiotherapy: Clinical Advances and Research Opportunities in Measurement for Survivorship. Clin Oncol (R Coll Radiol). 2015; 27(11):679-85. DOI: 10.1016/j.clon.2015.07.007. View

13.

Azoury F, Heymann S, Acevedo C, Spielmann M, Vielh P, Garbay J . Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation. Radiother Oncol. 2012; 103(2):193-8. DOI: 10.1016/j.radonc.2012.03.019. View

14.

Jandoo T . WHO guidance for digital health: What it means for researchers. Digit Health. 2020; 6:2055207619898984. PMC: 6952850. DOI: 10.1177/2055207619898984. View

15.

Liu D, Zheng Z, Zhang S, Zhu C, Zhang H, Zhou Y . Analysis of risk factors related to acute radiation dermatitis in breast cancer patients during radiotherapy. J Cancer Res Ther. 2023; 18(7):1903-1909. DOI: 10.4103/jcrt.jcrt_1203_22. View

16.

Thornton M, Lewis-Smith H . "": a qualitative exploration of positive body image in breast cancer survivors . Psychol Health. 2021; 38(2):249-268. DOI: 10.1080/08870446.2021.1956494. View

17.

Fuzissaki M, Paiva C, de Oliveira M, Canto P, Maia Y . The Impact of Radiodermatitis on Breast Cancer Patients' Quality of Life During Radiotherapy: A Prospective Cohort Study. J Pain Symptom Manage. 2019; 58(1):92-99.e1. DOI: 10.1016/j.jpainsymman.2019.03.017. View

18.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

19.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

20.

Beamer L, Grant M . Using the Dermatology Life Quality Index to Assess How Breast Radiodermatitis Affects Patients' Quality of Life. Breast Cancer (Auckl). 2019; 13:1178223419835547. PMC: 6463233. DOI: 10.1177/1178223419835547. View